Signet Financial Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-900	Closed	-$9K	–	990
2018 Q1	$9K	Buy	+900	New	+$9K	﹤0.01%	586